Sigma Healthcare Ltd · GETTEX:S5YA

Sigma Healthcare Ltd financial statements

Sigma Healthcare Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue10.8B4.89B3.32B3.66B3.45B3.40B3.24B3.98B4.09B4.37B
Cost of revenue8.88B4.56B3.13B3.44B3.25B3.19B3.06B3.70B3.81B4.08B
Gross profit1.96B334.1M189.8M224.1M199.4M210.6M187.8M273.2M284.4M289.5M
Selling, general and administrative461.8M384.0M88.6M82.6M93.0M94.4M68.0M63.6M65.6M59.5M
Operating income998.0M722.6M-71.9M-68.9M-110.2M-98.4M-101.0M-36.4M83.4M15.2M
Depreciation and amortization85.0M56.0M28.3M30.3M27.7M31.0M27.3M13.5M9.09M8.29M
EBITDA1.08B778.6M-43.6M-38.6M-82.5M-67.4M-73.7M-22.9M92.4M23.5M
Interest expense114.2M18.5M16.3M14.4M10.8M11.8M13.4M11.8M6.47M6.02M
Income before tax1.01B743.5M8.62M5.46M-8.31M28.6M-15.8M52.0M78.7M76.7M
Income tax296.4M218.0M3.31M2.44M-1.97M-16.5M-4.29M14.9M23.3M23.2M
Net income709.2M529.9M4.51M1.81M-7.24M43.5M-12.3M36.5M55.1M53.2M
Earnings per share, basic0.060.030.000.00-0.000.00-0.000.000.010.00

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents131.1M14.6M356.5M16.6M31.1M16.1M104.2M72.6M82.2M24.4M
Short-term investments-7.67M014.0K0
Receivables2.01B952.7M320.0M332.5M343.3M327.3M277.7M549.4M550.5M537.0M
Inventory1.25B383.4M221.1M324.9M321.6M349.1M315.5M343.3M350.5M322.0M
Current assets3.43B1.38B912.5M685.8M761.6M702.2M735.9M1.00B1.03B918.7M
Property, plant and equipment256.1M271.8M290.9M281.6M288.3M299.4M224.1M128.5M77.9M
Goodwill3.63B89.1M89.1M95.2M103.0M103.0M103.0M93.1M93.1M80.8M
Total assets8.91B1.83B1.40B1.20B1.28B1.22B1.23B1.38B1.30B1.12B
Accounts payable1.30B726.4M303.4M406.0M352.3M365.5M360.0M492.8M526.5M475.3M
Current liabilities2.05B865.0M371.3M477.4M457.6M523.7M576.0M663.3M781.0M574.6M
Long-term debt752.2M855.3M080.0M165.0M0115.2M200.8M788.0K1.02M
Total debt2.02B132.1M136.6M227.0M323.4M215.2M300.2M315.8M195.8M33.2M
Total liabilities3.92B991.3M531.5M723.8M786.7M705.0M752.7M869.6M789.5M580.3M
Shareholders' equity5.00B837.9M870.8M475.9M487.2M513.7M476.0M513.3M513.1M536.8M
Shares outstanding11.5B15.7B10.6B10.3B10.2B10.3B10.1B10.1B10.3B10.7B

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations574.6M598.8M42.0M33.4M27.7M12.5M200.6M8.47M71.2M145.8M
Capital spending-56.7M-7.91M-4.72M-29.4M-14.2M-77.0M-57.1M-108.2M-62.3M-25.2M
Free cash flow517.9M-323.5M37.2M3.96M13.5M-64.6M143.5M-99.7M8.89M120.6M
Cash from investing62.6M-1.60M5.73M-28.6M-16.6M98.8M-68.4M-101.6M-94.5M-30.5M
Cash from financing-645.2M-24.7M295.8M-116.9M128.9M-265.7M-100.6M83.5M113.3M-67.5M
Dividends paid-378.8M-17.1M-9.98M-15.9M-19.9M-1.59M-30.7M-41.0M-55.2M-55.7M
Share buybacks2.68M-9.50M879.0K195.0K-50.0K-50.0K-4.14M-30.7M-24.6M
Change in cash-7.65M-341.9M343.5M-2.80M66.0M-154.5M31.6M-9.64M90.0M47.9M